Literature DB >> 8879383

Ifosfamide encephalopathy and methylene-blue: a case report.

J L Alonso, Y Nieto, J A López, M Martín, E Díaz-Rubio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8879383     DOI： 10.1093/oxfordjournals.annonc.a010686

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

Review 2.  Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Authors:  Karen I Sweiss; Rakesh Beri; Stacy S Shord
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Authors:  J Pelgrims; F De Vos; J Van den Brande; D Schrijvers; A Prové; J B Vermorken
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.

Authors:  Cindy Banh; Kendall Valsvik; Alejandra Arredondo; Kassie Notbohm; Emad Elquza; Hani Babiker; Andrew Kraft; Alejandro Recio Boiles; Daniel Persky; Alicia Ortega; Ali McBride
Journal:  Support Care Cancer       Date:  2021-11-26       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.